194 related articles for article (PubMed ID: 26242267)
1. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
Cai J; Shen G; Liu S; Meng Q
Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
[TBL] [Abstract][Full Text] [Related]
2. HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma.
Meng Q; Zhao J; Liu H; Zhou G; Zhang W; Xu X; Zheng M
Tumour Biol; 2014 Dec; 35(12):12265-74. PubMed ID: 25168370
[TBL] [Abstract][Full Text] [Related]
3. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
5. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro.
Ling YX; Tao J; Fang SF; Hui Z; Fang QR
Eur J Cancer Prev; 2011 Jan; 20(1):9-17. PubMed ID: 20881502
[TBL] [Abstract][Full Text] [Related]
7. High-mobility group A2 overexpression is an unfavorable prognostic biomarker for nasopharyngeal carcinoma patients.
Liu Z; Wu K; Yang Z; Wu A
Mol Cell Biochem; 2015 Nov; 409(1-2):155-62. PubMed ID: 26183485
[TBL] [Abstract][Full Text] [Related]
8. MiR-1297 promotes apoptosis and inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting HMGA2.
Liu Y; Liang H; Jiang X
Int J Mol Med; 2015 Nov; 36(5):1345-52. PubMed ID: 26398017
[TBL] [Abstract][Full Text] [Related]
9. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
Xiang J; Bian C; Wang H; Huang S; Wu D
J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908
[TBL] [Abstract][Full Text] [Related]
10. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition.
Lee J; Ha S; Jung CK; Lee HH
Int J Oncol; 2015; 46(6):2431-8. PubMed ID: 25845850
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-Ras and HMGA2 gene expression.
Wang YY; Ren T; Cai YY; He XY
Cancer Biother Radiopharm; 2013 Mar; 28(2):131-7. PubMed ID: 23134218
[TBL] [Abstract][Full Text] [Related]
12. RKIP inhibits gastric cancer cell survival and invasion by regulating the expression of HMGA2 and OPN.
Liu H; Li P; Li B; Sun P; Zhang J; Wang B; Jia B
Tumour Biol; 2014 Dec; 35(12):11949-58. PubMed ID: 25172097
[TBL] [Abstract][Full Text] [Related]
13. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.
Wu J; Wang Y; Xu X; Cao H; Sahengbieke S; Sheng H; Huang Q; Lai M
Carcinogenesis; 2016 May; 37(5):511-21. PubMed ID: 26964871
[TBL] [Abstract][Full Text] [Related]
15. Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro.
Lei X; Chang L; Ye W; Jiang C; Zhang Z
Int J Clin Exp Pathol; 2015; 8(11):14214-20. PubMed ID: 26823735
[TBL] [Abstract][Full Text] [Related]
16. HMGA2 expression in a canine model of prostate cancer.
Winkler S; Murua Escobar H; Meyer B; Simon D; Eberle N; Baumgartner W; Loeschke S; Nolte I; Bullerdiek J
Cancer Genet Cytogenet; 2007 Sep; 177(2):98-102. PubMed ID: 17854662
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
[TBL] [Abstract][Full Text] [Related]
18. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
[TBL] [Abstract][Full Text] [Related]
19. miR-154 inhibits EMT by targeting HMGA2 in prostate cancer cells.
Zhu C; Li J; Cheng G; Zhou H; Tao L; Cai H; Li P; Cao Q; Ju X; Meng X; Wang M; Zhang Z; Qin C; Hua L; Yin C; Shao P
Mol Cell Biochem; 2013 Jul; 379(1-2):69-75. PubMed ID: 23591597
[TBL] [Abstract][Full Text] [Related]
20. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]